Kcl + Glucose, Viaflo Baxter

Potassium chloride and glucose, the active ingredient in Kcl + Glucose, Viaflo Baxter, is an electrolyte and carbohydrate solution presented as an injection solution for intravenous use. It corrects low blood potassium, supplies glucose for energy, and supports fluid and electrolyte balance in hospitalized patients.

GNH USA supplies Kcl + Glucose, Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The product is manufactured in the European Union under strict quality standards and is available for global distribution to meet clinical demand.

Kcl + Glucose, Viaflo Baxter is used to manage electrolyte and carbohydrate needs in several clinical situations. - Hypokalemia: restores serum potassium to normal levels, preventing cardiac and muscular complications. - Potassium supplementation: provides essential potassium ions for patients with deficient intake or losses. - Fluid and electrolyte replenishment: corrects deficits in body fluids and electrolytes during dehydration or illness. - Prevention or treatment of hypoglycemia: supplies glucose to raise blood sugar and support metabolic demands. - Post‑operative or peri‑operative fluid management: maintains electrolyte balance and energy supply during surgical recovery.

Kcl + Glucose, Viaflo Baxter may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Injection site irritation: redness, pain, or swelling at the infusion site. - Hyperkalemia: elevated serum potassium levels, especially with rapid infusion. - Hyperglycemia: transient rise in blood glucose concentrations. - Nausea or vomiting: gastrointestinal discomfort following administration. - Headache: mild to moderate head pain. - Dizziness: feeling of light‑headedness or imbalance.

Serious or Rare Side Effects: - Cardiac arrhythmia: potentially life‑threatening rhythm disturbances due to potassium imbalance. - Severe hyperkalemia: risk of cardiac arrest if potassium exceeds safe limits. - Anaphylactic reaction: rare hypersensitivity with rash, bronchospasm, or hypotension. - Severe hyperglycemia: may precipitate diabetic ketoacidosis in susceptible patients. - Thrombophlebitis: inflammation of vein with clot formation at infusion site. - Metabolic acidosis: rare disturbance of acid‑base balance.

When using Kcl + Glucose, Viaflo Baxter, clinicians should observe specific safety measures to minimize risks. - Renal impairment: monitor serum potassium and adjust infusion rate. - Cardiac disease: obtain baseline ECG and watch for arrhythmias. - Diabetes mellitus: check blood glucose frequently and titrate glucose infusion. - Concomitant potassium‑sparing agents: avoid combined use to prevent hyperkalemia. - Pregnancy: prescribe only if potential benefit outweighs risk to the fetus. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kcl + Glucose, Viaflo Baxter can interact with other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may potentiate hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of dangerous potassium elevation. - Digitalis glycosides: heightened risk of cardiac toxicity with high potassium.

Moderate Interactions (Monitor Closely): - Insulin therapy: glucose infusion may require insulin dose adjustment. - Beta‑blockers: may mask signs of hypoglycemia during glucose administration.